CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:CAR T cell infiltration and cytotoxic killing within the core of 3D breast cancer spheroids under control of antigen sensing in microwell arrays.
CAR T cell infiltration and cytotoxic killing within the core of 3D breast cancer spheroids under control of antigen sensing in microwell arrays.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
嵌合抗原受体(CAR)T 细胞在血液系统恶性肿瘤中的成功,推动了实体瘤 CAR-T 疗法的研发。在实体瘤微环境中,CAR-T 细胞迁移和细胞毒性杀伤受抑是限制疗效的因素。
本研究建立微孔平台,用于研究 CAR-T 细胞与三维肿瘤球体的相互作用,并确定预测其抗肿瘤功能的指标。为精确控制 CAR-T 对抗原的识别,研究使用可切换衔接分子 CAR 系统:该系统并非直接结合目标抗原,而是与共同给药的抗体衔接分子共价结合,由后者介导肿瘤抗原识别。加入抗 HER2 衔接抗体后,原代人 CAR-T 细胞的浸润和聚集均高于未加衔接抗体的对照。通过逐个追踪肿瘤球体水平的 CAR-T 杀伤,研究显示球体尺寸具有抑制作用,并发现初始 CAR-T 细胞与肿瘤球体面积比可预测细胞毒性。时空分析显示,肿瘤球体核心区的 CAR-T 细胞数量及细胞毒性低于周边区域。提高 CAR-T 接种密度后,核心区的 CAR-T 浸润和癌细胞清除均增加。这些发现为 CAR-T 细胞介导的 HER2 阳性乳腺肿瘤细胞杀伤提供了新的定量认识。该微型化且具备活细胞成像能力的微加工系统,有望用于发现调控 CAR-T 抗肿瘤功能的细胞间作用机制,并在三维肿瘤模型中筛选细胞免疫疗法。
The success of chimeric antigen receptor (CAR) T cells in blood cancers has intensified efforts to develop CAR T therapies for solid cancers. In the solid tumor microenvironment, CAR T cell trafficking and suppression of cytotoxic killing represent limiting factors for therapeutic efficacy.
Here, we present a microwell platform to study CAR T cell interactions with 3D tumor spheroids and determine predictors of anti-tumor CAR T cell function. To precisely control antigen sensing by CAR T cells, we utilized a switchable adaptor CAR system, that instead of directly binding to an antigen of interest, covalently attaches to co-administered antibody adaptors that mediate tumor antigen recognition.
Following addition of an anti-HER2 adaptor antibody, primary human CAR T cells exhibited higher infiltration and clustering compared to the no adaptor control. By tracking CAR T cell killing at the individual spheroid level, we showed the suppressive effects of spheroid size and identified the initial CAR T cell : spheroid area ratio as a predictor of cytotoxicity. Spatiotemporal analysis revealed lower CAR T cell numbers and cytotoxicity in the spheroid core compared to the periphery.
Finally, increasing CAR T cell seeding density, resulted in higher CAR T cell infiltration and cancer cell elimination in the spheroid core.
Our findings provide new quantitative insights into CAR T cell-mediated killing of HER2+ breast tumor cells. Given the miniaturized nature and live imaging capabilities, our microfabricated system holds promise for discovering cell-cell interaction mechanisms that orchestrate antitumor CAR T cell functions and screening cellular immunotherapies in 3D tumor models.
MEMBER ACCOUNT
登录成功会直接打开下一页。